simeprevir
Ligand Summary
Oral HCV-PROTEASE INHIBITOR effective against hepatitis C virus (HCV) serine protease NS3/4A. It is used in the treatment of chronic hepatitis C (Antivirals) genotype 1 infection in adults with compensated liver disease, including CIRRHOSIS.
UNII: 9WS5RD66HZ
PubChem: 24873435
ChEMBL: CHEMBL501849
DrugCentral: 4812
LyCHI: G7F7Q6ZWA7QY
Target Activities
2 Activities
Items per page:
10
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
|---|---|---|---|---|---|---|
IC50 | ||||||
IC50 | ||||||